เอกสารอ้างอิง
1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 2018;38(1):1-211.
2. Wolters Kluwer. Ergotamine [Internet]. Wolters Kluwer Clinical Drug Information: AccessMedicine; 2022 [cited 2022 Jul 13]. Available from: https://accessmedicine.mhmedical.com/
3. Elsevier. Ergotamine [Internet]. Elsevier: ClinicalKey; 2022 [cited 2022 Jul 13]. Available from: https://www.clinicalkey.com.
4. Dahlöf C, Van Den Brink AM. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Headache 2012;52(4):707-714.
5. Wolters Kluwer. Ergotamine [Internet]. Wolters Kluwer Clinical Drug Information: AccessMedicine; 2022 [cited 2022 Jul 13]. Available from: https://accessmedicine.mhmedical.com.
6. Elsevier. Ergotamine [Internet]. Elsevier: ClinicalKey; 2022 [cited 2022 Jul 13]. Available from: https://www.clinicalkey.com.
7. Miljković S, Smajlović Dz, Tirić Campara M, et al. The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura. Hippokratia 2018;22(1):17-22.
8. Mayans L, Walling A. Acute migraine headache: treatment strategies. Am Fam Physician 2018;97(4):243-251.
9. National Institute for Health and care Excellence. Headaches in over 12s: diagnosis and management [Internet]. 2021 [cited 2022 Jul 13]. Available from https://www.nice.org.uk.
10. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):487-499.
11. สมาคมประสาทวิทยาแห่งประเทศไทย. ร่างแนวทางเวชปฏิบัติการวินิจฉัยและการรักษาปวดศีรษะไมเกรน [อินเทอร์เน็ต]. 2565 [เข้าถึงเมื่อ 13 กรกฎาคม 2565]. เข้าถึงได้จาก http://www.neurothai.org.